Invasive pulmonary aspergillosis after liver transplantation: Rapid and complete response to combined and sequential antifungal therapy

Surgical Infections

Volumn 9, Issue 1, 2008, Pages 99-104

  Can, Mehmet Fatih ^a,b   Yagci, Gokhan ^a   Gorenek, Levent ^a   Tozkoparan, Ergun ^a   Ozerhan, Ismail ^a   Cetiner, Sadettin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; CANSIDAS; CASPOFUNGIN; CORTICOSTEROID; COTRIMOXAZOLE; FLUCONAZOLE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; CYTOMEGALOVIRUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; INFECTION CONTROL; LANGUAGE; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG ASPERGILLOSIS; MALE; MEDICAL LITERATURE; PNEUMOCYSTIS; PNEUMOCYSTIS JEROVECII; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; DRUG THERAPY, COMBINATION; ECHINOCANDINS; HUMANS; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PYRIMIDINES; RADIOGRAPHY, THORACIC; TOMOGRAPHY, EMISSION-COMPUTED; TRIAZOLES;

EID: 41149137050     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.094     Document Type: Article

References (15)

1. Dunn DL. Hazardous crossing: Immunosuppression and nosocomial infections in solid organ transplant recipients. Surg Infect 2001;2:103-110.
2. Ergin F, Arslan H, Azap A, et al. Invasive aspergillosis in solid-organ transplantation: Report of eight cases and review of the literature. Transplant Int 2003;16:280-286.
3. Paya CV. Prevention of fungal infection in transplantation. Transplant Infect Dis 2002;4:46-51.
4. Perfect JR. New antifungal agents. Transplant Infect Dis 2002;4:52-61.
5. Fortun J, Martin-Davila P, Moreno S, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transplant 2002;8:1065-1070.
6. Fung JJ. Fungal infection in liver transplantation. Transplant Infect Dis 2002;4:18-23.
7. Fishman JA. Overview: Fungal infections in the transplant patient. Transplant Infect Dis 2002;4:3-11.
8. Hagerty JA, Ortiz J, Reich D, Manzarbeitia C. Fungal infections in solid organ transplant patients. Surg Infect 2003;4:263-271.
9. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415.
10. Dannaoui E, Lortholary O, Dromer F. In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother 2004;48:970-978.
11. Sionov E, Mendlovic S, Segal E. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis. J Infect 2006;53:131-139.
12. Johnson MD, MacDougall C, Ostrosky-Zeichner L, et al. Combination antifungal therapy. Antimicrob Agents Chemother 2004;48:693-715.
13. Aliff TB, Maslak PG, Jurcic JG et al. Refractory Aspergillus pneumonia in patients with acute leukemia: Successful therapy with combination caspofungin and liposomal amphotericin. Cancer 2003;97:1025-1032.
14. Cesaro S, Toffolutti T, Messina C, et al. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Eur J Haematol 2004;73:50-55.
15. Nivoix Y, Zamfir A, Lutun P, et al. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. J Infect 2006;52:67-74.